# Diversified Healthcare Trust: filings

DHC · Nasdaq · CIK 1075415 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dhc.md) · [Financials](/companies/dhc/financials.md) · [Filings](/companies/dhc/filings.md) · [Insiders](/companies/dhc/insiders.md)

## Reports and events: 334 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 223, 8-K 222, SC 13G/A 59, 10-Q 53, 425 40, 424B5 35, DEFA14A 22, UPLOAD 21, 10-K 18, DEF 14A 18, SC 13G 18, 3 14, SC 13D/A 13, DFAN14A 12, ARS 11, CORRESP 11, FWP 9, SC 13D 6, 4/A 5, 8-A12B 5, S-3ASR 5, SCHEDULE 13G/A 4, 25 3, 8-K/A 3, POSASR 3, PX14A6G 3, S-8 3, 424B3 2, CERTNYS 2, PRE 14A 2, PRRN14A 2, 15-12B 1, 25-NSE 1, CERTNAS 1, DEFC14A 1, DEFM14A 1, DEL AM 1, EFFECT 1, PREC14A 1, S-3 1, SCHEDULE 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-12 | 17:01 ET | [SCHEDULE 13D/A](/filings/0001687639-26-000001.md) | Ownership report, active investor, amended | 0001687639-26-000001 |
| 2026-08-03 | 16:47 ET | [10-Q](/filings/0001075415-26-000030.md) | Quarterly report, period 2026-06-30 | 0001075415-26-000030 |
| 2026-08-03 | 16:24 ET | [8-K](/filings/0001075415-26-000029.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001075415-26-000029 |
| 2026-06-12 | 16:08 ET | [8-K](/filings/0001104659-26-073447.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-073447 |
| 2026-06-01 | 16:03 ET | [8-K](/filings/0001104659-26-068894.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-068894 |
| 2026-05-05 | 08:05 ET | [8-K](/filings/0001104659-26-055290.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-055290 |
| 2026-05-04 | 16:56 ET | [10-Q](/filings/0001075415-26-000024.md) | Quarterly report, period 2026-03-31 | 0001075415-26-000024 |
| 2026-05-04 | 16:26 ET | [8-K](/filings/0001075415-26-000022.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001075415-26-000022 |
| 2026-03-19 | 16:12 ET | [DEF 14A](/filings/0001104659-26-032082.md) | Proxy statement, period 2026-06-10 | 0001104659-26-032082 |
| 2026-02-24 | 08:05 ET | [8-K](/filings/0001104659-26-018853.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-018853 |
| 2026-02-24 | 17:41 ET | [10-K](/filings/0001075415-26-000013.md) | Annual report, period 2025-12-31 | 0001075415-26-000013 |
| 2026-02-23 | 16:25 ET | [8-K](/filings/0001075415-26-000010.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001075415-26-000010 |
| 2026-01-14 | 08:15 ET | [8-K](/filings/0001104659-26-003559.md) | 2.02 Results of operations; 8.01 Other events | 0001104659-26-003559 |
| 2026-01-05 | 08:12 ET | [8-K](/filings/0001104659-26-000422.md) | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001104659-26-000422 |
| 2025-12-08 | 16:24 ET | [8-K](/filings/0001104659-25-119312.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-119312 |
| 2025-11-03 | 17:28 ET | [10-Q](/filings/0001075415-25-000044.md) | Quarterly report, period 2025-09-30 | 0001075415-25-000044 |
| 2025-11-03 | 17:21 ET | [8-K](/filings/0001075415-25-000043.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001075415-25-000043 |
| 2025-10-08 | 07:59 ET | [8-K](/filings/0001104659-25-097738.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-097738 |
| 2025-09-29 | 07:56 ET | [8-K](/filings/0001104659-25-094123.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-094123 |
| 2025-09-03 | 08:10 ET | [8-K](/filings/0001104659-25-086699.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-086699 |
| 2025-08-04 | 17:13 ET | [10-Q](/filings/0001075415-25-000033.md) | Quarterly report, period 2025-06-30 | 0001075415-25-000033 |
| 2025-08-04 | 16:35 ET | [8-K](/filings/0001075415-25-000031.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001075415-25-000031 |
| 2025-06-02 | 16:21 ET | [8-K](/filings/0001104659-25-055464.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-055464 |
| 2025-06-02 | 16:12 ET | [8-K](/filings/0001104659-25-055454.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-25-055454 |
| 2025-05-22 | 08:00 ET | [8-K](/filings/0001104659-25-051839.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-051839 |
| 2025-05-05 | 16:56 ET | [10-Q](/filings/0001075415-25-000024.md) | Quarterly report, period 2025-03-31 | 0001075415-25-000024 |
| 2025-05-05 | 16:35 ET | [8-K](/filings/0001075415-25-000021.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001075415-25-000021 |
| 2025-03-20 | 16:55 ET | [DEF 14A](/filings/0001104659-25-026223.md) | Proxy statement, period 2025-05-29 | 0001104659-25-026223 |
| 2025-03-20 | 16:47 ET | [8-K](/filings/0001104659-25-026209.md) | 5.02 Departure or appointment of officers or directors | 0001104659-25-026209 |
| 2025-02-26 | 08:41 ET | [8-K](/filings/0001104659-25-017257.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-017257 |
| 2025-02-25 | 16:57 ET | [10-K](/filings/0001075415-25-000012.md) | Annual report, period 2024-12-31 | 0001075415-25-000012 |
| 2025-02-25 | 16:46 ET | [8-K](/filings/0001075415-25-000011.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001075415-25-000011 |
| 2025-02-03 | 16:55 ET | [8-K](/filings/0001075415-25-000003.md) | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001075415-25-000003 |
| 2024-11-18 | 07:02 ET | [8-K](/filings/0001104659-24-119929.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-119929 |
| 2024-11-04 | 16:31 ET | [10-Q](/filings/0001075415-24-000031.md) | Quarterly report, period 2024-09-30 | 0001075415-24-000031 |
| 2024-11-04 | 16:30 ET | [8-K](/filings/0001075415-24-000030.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001075415-24-000030 |
| 2024-10-09 | 20:53 ET | [SC 13D/A](/filings/0001104659-24-107426.md) | Ownership report, active investor, amended | 0001104659-24-107426 |
| 2024-08-01 | 16:22 ET | [10-Q](/filings/0001075415-24-000023.md) | Quarterly report, period 2024-06-30 | 0001075415-24-000023 |
| 2024-08-01 | 16:18 ET | [8-K](/filings/0001075415-24-000022.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001075415-24-000022 |
| 2024-06-04 | 16:06 ET | [8-K](/filings/0001104659-24-068240.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-24-068240 |
| 2024-06-03 | 16:12 ET | [8-K](/filings/0001104659-24-067781.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-067781 |
| 2024-05-21 | 16:15 ET | [8-K](/filings/0001104659-24-063845.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-063845 |
| 2024-05-06 | 16:29 ET | [10-Q](/filings/0001075415-24-000015.md) | Quarterly report, period 2024-03-31 | 0001075415-24-000015 |
| 2024-05-06 | 16:27 ET | [8-K](/filings/0001075415-24-000014.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001075415-24-000014 |
| 2024-03-26 | 16:32 ET | [DEF 14A](/filings/0001104659-24-039058.md) | Proxy statement, period 2024-05-31 | 0001104659-24-039058 |
| 2024-02-26 | 16:54 ET | [10-K](/filings/0001075415-24-000007.md) | Annual report, period 2023-12-31 | 0001075415-24-000007 |
| 2024-02-26 | 16:35 ET | [8-K](/filings/0001075415-24-000005.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001075415-24-000005 |
| 2023-12-22 | 14:43 ET | [SC 13D/A](/filings/0000919574-23-006828.md) | Ownership report, active investor, amended | 0000919574-23-006828 |
| 2023-12-22 | 07:46 ET | [8-K](/filings/0001104659-23-128518.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-128518 |
| 2023-11-20 | 08:30 ET | [8-K](/filings/0001104659-23-119746.md) | 5.02 Departure or appointment of officers or directors | 0001104659-23-119746 |

Page 1 of 7. [Older](/companies/dhc/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:03 ET. No prices; not investment advice.